CXCL8, an underestimated "bad guy" in prostate cancer.

@article{Culig2013CXCL8AU,
  title={CXCL8, an underestimated "bad guy" in prostate cancer.},
  author={Zoran Culig},
  journal={European urology},
  year={2013},
  volume={64 2},
  pages={
          189-90; discussion 190-2
        }
}
Although recent major advances in experimental and clinical therapies for prostate cancer are related to the inhibition of the androgen signaling pathway, the clinical significance of chemokines should not be neglected. At this stage, it should be emphasized that we need more and better models to understand the events that lead from chronic inflammation through intraepithelial atrophy, high-grade prostate intraepithelial neoplasia to clinically manifest prostate cancer. At present, a lot of our… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 10 REFERENCES